Delivery Order SPE2DB24D2012-SPE2DB25FBWWB
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $9,140.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,875.17 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. This firm fixed price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 4, 2025. The contract was awarded on August 1, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location, the...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.32 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injectors on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order was placed under a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award reflects the agency's need for this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,205.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist commonly prescribed for weight management. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $21,121.26 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric formulation of semaglutide, a glucagon-like peptide-1 receptor agonist used for chronic weight management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,819.81 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen (semaglutide injection) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $12,468.03 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. The contract was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, under firm fixed pricing terms with no set-aside designation. Performance will take place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $3,229.56 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Zepbound 10 mg/0.5 mL pen (semaglutide), a medication used for weight management. This firm fixed-price, non-set-aside delivery order will be completed by August 29, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a $16,675.15 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price contract, which was not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves...